AbbVie Inc. Long-Term Debt 2012-2026 | ABBV
Beta
What is long-term debt?
Long-term debt includes bonds, mortgages, and other borrowings with maturities greater than one year.
What is AbbVie Inc.'s current long-term debt?
AbbVie Inc. (ABBV) annual long-term debt for 2025 was $58.94B, a 2.32% decline from 2024. AbbVie Inc. long-term debt for the quarter ending March 31, 2026 was $64.53B.
What was AbbVie Inc.'s long-term debt in 2024?
AbbVie Inc. annual long-term debt for 2024 was $60.34B, a 15.61% increase from 2023.
What was AbbVie Inc.'s long-term debt in 2023?
AbbVie Inc. annual long-term debt for 2023 was $52.19B, a 11.74% decline from 2022.
What is AbbVie Inc.'s 5-year long-term debt CAGR?
AbbVie Inc. long-term debt grew at a compound annual growth rate (CAGR) of 5.34% from FY2020 to FY2025, going from $77.55B to $58.94B over 5 years.
Long-Term Debt History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-5.3%
FY2020
$77.55B
→
FY2025
$58.94B
1213141516171819202122232425
5 years selected
Long-Term Debt History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $58.94B | -2.3% | 10-K |
| FY2024 | $60.34B | +15.6% | 10-K |
| FY2023 | $52.19B | -11.7% | 10-K |
| FY2022 | $59.13B | -7.9% | 10-K |
| FY2021 | $64.19B | -17.2% | 10-K |
| FY2020 | $77.55B | +23.2% | 10-K |
| FY2019 | $62.98B | +79.9% | 10-K |
| FY2018 | $35.00B | +13.1% | 10-K |
| FY2017 | $30.95B | -15.1% | 10-K |
| FY2016 | $36.44B | +24.6% | 10-K |
| FY2015 | $29.24B | +177.5% | 10-K |
| FY2014 | $10.54B | -26.3% | 10-K |
| FY2013 | $14.29B | -2.3% | 10-K |
| FY2012 | $14.63B | - | 10-K |
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →